GlassScriptPhysician profile
Beau C Vesely
NPI 1164833430
$1,616.71
in general payments reported to CMS, 2019-2025
8 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $94.16 · 2021: $13.05 · 2022: $183 · 2023: $460 · 2024: $369 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $696.07 | 2020-2025 | Citrefix, Augment Injectable, Inbone |
| Smith+Nephew, INC. | $504.72 | 2019-2024 | Stravix, Stravix Pl, Grafix |
| Flower Orthopedics Coporation | $132.94 | 2024 | |
| Osiris Therapeutics INC. | $123.16 | 2019 | |
| Abbvie INC. | $96.20 | 2023 | Dalvance |
| Solventum Corporation | $40.05 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Kci USA, INC. | $14.96 | 2023 | Snap, Promogran Prisma, Activ.A.C. |
| Orthofix Medical, INC. | $8.61 | 2025 | Accelstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beau Vesely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.